{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T05:40:33Z","timestamp":1761716433661},"reference-count":26,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2001,5,1]],"date-time":"2001-05-01T00:00:00Z","timestamp":988675200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Pediatrics"],"published-print":{"date-parts":[[2001,5]]},"DOI":"10.1067\/mpd.2001.112246","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T00:21:43Z","timestamp":1027556503000},"page":"710-714","source":"Crossref","is-referenced-by-count":23,"title":["Identification of poor responders to erythropoietin among children undergoing hemodialysis"],"prefix":"10.1067","volume":"138","author":[{"given":"Wacharee","family":"Seeherunvong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liliana","family":"Rubio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolyn L.","family":"Abitbol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brenda","family":"Montan\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose","family":"Strauss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa","family":"Diaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gast\u00f3n","family":"Zilleruelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1067\/mpd.2001.112246_bib1","first-page":"2","article-title":"Guidelines for recombinant human erythropoietin therapy","volume":"14","author":"Eschbach","year":"1989","journal-title":"Am J Kidney Dis"},{"key":"10.1067\/mpd.2001.112246_bib2","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1056\/NEJM198907203210305","article-title":"Treatment of the anemia of progressive renal failure with recombinant human erythropoietin","volume":"321","author":"Eschbach","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1067\/mpd.2001.112246_bib3","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/BF00866354","article-title":"A study of recombinant human erythropoietin in the treatment of anaemia of chronic renal failure in children on haemodialysis","volume":"8","author":"Van Damme-Lombaerts","year":"1994","journal-title":"Pediatr Nephrol"},{"key":"10.1067\/mpd.2001.112246_bib4","first-page":"S192","volume":"30","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"10.1067\/mpd.2001.112246_bib5","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/ndt\/10.supp2.69","article-title":"R-HuEPO hyporesponsiveness\u2014who and why?","volume":"10","author":"Danielson","year":"1995","journal-title":"Nephrol Dial Transplant"},{"key":"10.1067\/mpd.2001.112246_bib6","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1093\/ndt\/10.supp2.62","article-title":"R-HuEPO hyporesponsiveness\u2014who and why?","volume":"10","author":"Drueke","year":"1995","journal-title":"Nephrol Dial Transplant"},{"key":"10.1067\/mpd.2001.112246_bib7","first-page":"456","article-title":"Primary results from the U.S. multicenter pediatric recombinant erythropoietin study [abstract]","volume":"5","author":"Jabs","year":"1994","journal-title":"J Am Soc Nephrol"},{"key":"10.1067\/mpd.2001.112246_bib8","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1177\/000992289203100206","article-title":"Therapy of renal anemia in children and adolescents with recombinant human erythropoietin (rHuEPO)","volume":"31","author":"Campos","year":"1992","journal-title":"Clin Pediatr (Phila)"},{"key":"10.1067\/mpd.2001.112246_bib9","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0022-3476(05)80688-2","article-title":"Benefits and risks of anemia correction with recombinant human erythropoietin in children maintained by hemodialysis","volume":"117","author":"Montini","year":"1990","journal-title":"J Pediatr"},{"key":"10.1067\/mpd.2001.112246_bib10","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1007\/s004670050352","article-title":"Recombinant human erythropoietin dosage in children undergoing hemodialysis and continuous ambulatory peritoneal dialysis","volume":"11","author":"Sieniawska","year":"1997","journal-title":"Pediatr Nephrol"},{"key":"10.1067\/mpd.2001.112246_bib11","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s004670050583","article-title":"Safety and efficacy of erythropoietin in children with chronic renal failure","volume":"13","author":"Brandt","year":"1999","journal-title":"Pediatr Nephrol"},{"key":"10.1067\/mpd.2001.112246_bib12","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s004670050458","article-title":"Effect of hyperparathyroidism on response to erythropoietin in children on dialysis","volume":"12","author":"Belsha","year":"1998","journal-title":"Pediatr Nephrol"},{"key":"10.1067\/mpd.2001.112246_bib13","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S1073-4449(96)80038-0","article-title":"Recombinant human erythropoietin therapy in children on dialysis","volume":"3","author":"Jabs","year":"1996","journal-title":"Adv Ren Replace Ther"},{"key":"10.1067\/mpd.2001.112246_bib14","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/ndt\/6.10.709","article-title":"Pharmacokinetics of recombinant human erythropoietin in children with renal failure","volume":"6","author":"Evans","year":"1991","journal-title":"Nephrol Dial Transplant"},{"key":"10.1067\/mpd.2001.112246_bib15","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0272-6386(99)70259-3","article-title":"Acute-phase response predicts erythropoietin resistance in hemodialysis and peritoneal dialysis patients","volume":"33","author":"Gunnell","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1067\/mpd.2001.112246_bib16","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0272-6386(97)90561-8","article-title":"Severity of AIDS and the response to EPO in uremia","volume":"30","author":"Ifudu","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"10.1067\/mpd.2001.112246_bib17","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1111\/j.1651-2227.1994.tb12978.x","article-title":"Ferritin levels in pediatric HIV-1 infection","volume":"83","author":"Ellaurie","year":"1994","journal-title":"Acta Paediatr"},{"key":"10.1067\/mpd.2001.112246_bib18","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1056\/NEJM199301213280304","article-title":"Effect of serum parathyroid hormone and bone marrow fibrosis on the response to erythropoietin in uremia","volume":"328","author":"Rao","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1067\/mpd.2001.112246_bib19","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1093\/oxfordjournals.ndt.a027212","article-title":"Inverse relationships between haemoglobin and ristocetin-induced platelet aggregation in haemodialysis patients under erythropoietin therapy","volume":"11","author":"Borawski","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"10.1067\/mpd.2001.112246_bib20","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1093\/oxfordjournals.ndt.a027868","article-title":"Relationship between haemoglobin, ristocetin-induced platelet aggregation and platelet surface glycoproteins GPIb and GPIIb\/IIIa in haemodialysis patients under therapy with recombinant human erythropoietin [letter]","volume":"13","author":"Liani","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"10.1067\/mpd.2001.112246_bib21","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0049-3848(95)91619-V","article-title":"A study of platelet functions, some hemostatic and fibrinolytic parameters in relation to serotonin in hemodialyzed patients under erythropoietin therapy","volume":"77","author":"Malyszko","year":"1995","journal-title":"Thromb Res"},{"key":"10.1067\/mpd.2001.112246_bib22","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0049-3848(98)00031-0","article-title":"Long-term effects of erythropoietin on platelet serotonin storage and platelet aggregation in hemodialysis patients with reference to ketanserin treatment","volume":"90","author":"Borawski","year":"1998","journal-title":"Thromb Res"},{"key":"10.1067\/mpd.2001.112246_bib23","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/(SICI)1096-8652(199810)59:2<105::AID-AJH1>3.0.CO;2-1","article-title":"Effect of recombinant human erythropoietin treatment on circulating reticulated platelets in uremic patients: association with early improvement in platelet function","volume":"59","author":"Tassies","year":"1998","journal-title":"Am J Hematol"},{"key":"10.1067\/mpd.2001.112246_bib24","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1159\/000187060","article-title":"Fibrinolytic capacity in hemodialysis patients treated with recombinant human erythropoietin","volume":"62","author":"Aunsholt","year":"1992","journal-title":"Nephron"},{"key":"10.1067\/mpd.2001.112246_bib25","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/S0272-6386(12)80607-X","article-title":"Impact of epoetin beta on dialyzer clearance and heparin requirements","volume":"18","author":"Spinowitz","year":"1991","journal-title":"Am J Kidney Dis"},{"key":"10.1067\/mpd.2001.112246_bib26","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/BF01095958","article-title":"Effect of human recombinant erythropoietin on bleeding time, platelet number and function in children with end-stage renal disease maintained by haemodialysis","volume":"5","author":"Fabris","year":"1991","journal-title":"Pediatr Nephrol"}],"container-title":["The Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347601371548?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347601371548?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,9]],"date-time":"2019-05-09T07:52:59Z","timestamp":1557388379000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022347601371548"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,5]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2001,5]]}},"alternative-id":["S0022347601371548"],"URL":"https:\/\/doi.org\/10.1067\/mpd.2001.112246","relation":{},"ISSN":["0022-3476"],"issn-type":[{"value":"0022-3476","type":"print"}],"subject":[],"published":{"date-parts":[[2001,5]]}}}